Literature DB >> 20101211

Viral epigenomes in human tumorigenesis.

A F Fernandez1, M Esteller.   

Abstract

Viruses are associated with 15-20% of human cancers worldwide. In the last century, many studies were directed towards elucidating the molecular mechanisms and genetic alterations by which viruses cause cancer. The importance of epigenetics in the regulation of gene expression has prompted the investigation of virus and host interactions not only at the genetic level but also at the epigenetic level. In this study, we summarize the published epigenetic information relating to the genomes of viruses directly or indirectly associated with the establishment of tumorigenic processes. We also review aspects such as viral replication and latency associated with epigenetic changes and summarize what is known about epigenetic alterations in host genomes and the implications of these for the tumoral process. The advances made in characterizing epigenetic features in cancer-causing viruses have improved our understanding of their functional mechanisms. Knowledge of the epigenetic changes that occur in the genome of these viruses should provide us with markers for following cancer progression, as well as new tools for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101211     DOI: 10.1038/onc.2009.517

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

Review 1.  [The epigenome. Target for innovative therapies in head and neck carcinoma].

Authors:  A Leipold; J Hess; K Zaoui
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

2.  Analysis of host genetic diversity and viral entry as sources of between-host variation in viral load.

Authors:  Andrew R Wargo; Alison M Kell; Robert J Scott; Gary H Thorgaard; Gael Kurath
Journal:  Virus Res       Date:  2012-01-30       Impact factor: 3.303

Review 3.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

Review 4.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

5.  Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.

Authors:  Lisa Mirabello; Chang Sun; Arpita Ghosh; Ana C Rodriguez; Mark Schiffman; Nicolas Wentzensen; Allan Hildesheim; Rolando Herrero; Sholom Wacholder; Attila Lorincz; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2012-03-23       Impact factor: 13.506

Review 6.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

7.  Association of atopic diseases and parvovirus B19 with acute lymphoblastic leukemia in childhood and adolescence in the northeast of Brazil.

Authors:  Joacilda da Conceição Nunes; Georgia Véras de Araujo; Marcelo Tavares Viana; Emanuel Sávio Cavalcanti Sarinho
Journal:  Int J Clin Oncol       Date:  2016-05-25       Impact factor: 3.402

Review 8.  Defining, distinguishing and detecting the contribution of heterogeneous methylation to cancer heterogeneity.

Authors:  Thomas R Pisanic; Pornpat Athamanolap; Tza-Huei Wang
Journal:  Semin Cell Dev Biol       Date:  2016-08-28       Impact factor: 7.727

9.  History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia.

Authors:  Gisele M Vasconcelos; Brock C Christensen; E Andrés Houseman; Jianqiao Xiao; Carmen J Marsit; John K Wiencke; Shichun Zheng; Margaret R Karagas; Heather H Nelson; Margaret R Wrensch; Karl T Kelsey; Maria S Pombo-de-Oliveira; Joseph L Wiemels
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

10.  Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Authors:  Elise Jacquin; Alice Baraquin; Rajeev Ramanah; Xavier Carcopino; Adrien Morel; Séverine Valmary-Degano; Ignacio G Bravo; Silvia de Sanjosé; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.